We also observed that the interferon-gamma (IFN-γ)-mediated signaling pathway was significantly active in patients in cluster 1, possibly inhibiting the secretion of the inflammatory factor interleukin-10 (IL-10), upregulating autoimmune function, and reducing susceptibility to infection by pathogenic microorganisms after IS (Prass et al., 2003). This evidence concerns the gene IL10 and infection.